CryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent Graft
ATLANTA, Dec. 2, 2019 |PRNewswire| -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-nside TAAA multibranch stent graft system for the endovascular treatment of thoraco-abdominal…
CryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent Graft
ATLANTA, Dec. 2, 2019 |PRNewswire| -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-nside TAAA multibranch stent graft system for the endovascular treatment of thoraco-abdominal…